Aravive Inc. (ARAV) Prices 3.33M Share Common Offering at $7.50/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/29/2026
- S&P 500 flat as higher bond yields counter tech optimism
- Anthropic prospectus shows $2T IPO ambition, warns of AI 'existential risk'
- Risk appetite remains concentrated in large-cap stocks, Citi says
- Netflix stock: Deutsche Bank gets bullish as valuation leaves room to run
- CarMax shares rise over 2% on strong earnings and revenue beat
- Bloom Energy shares fall on Oracle project halt
- Exclusive-Activist Jana pushes Fiserv to accelerate cost cuts and tap Palantir
- Stocks fall as higher oil prices, Treasury yields weigh
- Oppenheimer sees AI software winners as focus shifts to ROI
- S&P 500 breadth hits lowest level since dot-com bubble, Goldman says
After-Hours Movers 11/26: (ONTX) (TNXP) (BOX) Higher; (ARAV) (ATHX) (GES) Lower (more...)
November 26, 2019 6:00 PM ESTAfter-Hours Movers
Onconova Therapeutic (NASDAQ: ONTX) 13.4% HIGHER; Steven Cohen's fund Point72 Asset Management, L.P. disclosed a 9.99%, or 3,230,434 share, stake in the company.
Aravive, Inc. (Nasdaq: ARAV) 13.3% LOWER; announced that it has commenced an underwritten public offering of the sale of its shares of common stock.
Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) 13.3% HIGHER; received the official minutes from the Breakthrough Therapy Type B Clinical... More
Aravive Inc. (ARAV) Plans Public Offering of Common Stock
November 26, 2019 5:14 PM ESTAravive, Inc. (Nasdaq: ARAV), a clinical-stage biopharmaceutical company developing treatments designed to halt the progression of life-threatening diseases, including cancer and fibrosis, today announced that it has commenced an underwritten public offering of the sale of its shares of common stock. In connection with... More
